Ocular Therapeutix OCUL Earnings Call Transcripts

NASDAQ OCUL
$6.61 -0.24 (-3.50%)
At close: Nov 10, 2026 · 4:00 PM EST
1 earnings call on file for Ocular Therapeutix, Q1 2020. Each transcript opens in a new tab.
Latest earnings call

Ocular Therapeutix Q1 2020 Earnings Call

May 8, 2020 5,844 words · 25 min read
  • Donald NotmanChief Financial Officer
  • Antony MattessichPresident and Chief Executive Officer
  • Mike GoldsteinChief Medical Officer
Prepared remarks and the full analyst Q&A, speaker by speaker.
Earnings calls

Ocular Therapeutix Earnings Call Transcripts

Calls1
LatestMay 8, 2020
SinceQ1 2020

Fiscal 2020

All 1 Ocular Therapeutix transcript Register to get access to Ocular Therapeutix’s earnings call transcripts.